Cigna
CI
Market cap $91.8B

330.07 USD

+6.68

2.07%

At close Nov 21, 4:00 PM EST

After hours

330.07

+0.00

0.00%

1 day

2.07%

5 days

2.17%

1 month

3.07%

3 months

-3.60%

6 months

-1.88%

Year to date

6.44%

1 year

15.21%

5 years

26.85%

10 years

26.85%

About: Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.

Employees: 72,500

Financials Hospital & Medical Service Plans

0

Funds holding %

of 6,747 funds

0

Analysts bullish %

of 13 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

35% more call options, than puts

Call options by funds: $1.18B | Put options by funds: $880M

17% more funds holding in top 10

Funds holding in top 10: 29 [Q2] → 34 (+5) [Q3]

10% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 125

3% more repeat investments, than reductions

Existing positions increased: 601 | Existing positions reduced: 584

1% more funds holding

Funds holding: 1,632 [Q2] → 1,645 (+13) [Q3]

1% more capital invested

Capital invested by funds: $82.3B [Q2] → $82.8B (+$444M) [Q3]

1.98% less ownership

Funds ownership: 87.7% [Q2] → 85.71% (-1.98%) [Q3]

See Fund Rankings

Research analyst outlook

13 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$377

14%

upside

Avg. target

$403

22%

upside

High target

$438

33%

upside

13 analyst ratings

13 positive

100%

0 neutral

0%

0 negative

0%

Piper Sandler Jessica Tassan 0 / 0 met price target	19%upside $394	Overweight Reiterated	5 Nov 2024
Barclays Andrew Mok 0 / 0 met price target	27%upside $420	Overweight Maintained	5 Nov 2024
Deutsche Bank George Hill 0 / 0 met price target	19%upside $394	Buy Maintained	4 Nov 2024
Stephens & Co. Scott Fidel 0 / 0 met price target	24%upside $410	Overweight Reiterated	1 Nov 2024
RBC Capital Ben Hendrix 0 / 0 met price target	14%upside $377	Outperform Maintained	1 Nov 2024

See Analyst Rankings

Financial journalist opinion

Based on 28 articles about CI published over the past 30 days

CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices

CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional. The complaint is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.

CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices

Zacks Investment Research

Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips

CI reaffirms its 2024 outlook, projecting full-year adjusted EPS to be a minimum of $28.40.

Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips

CNBC Television

3-Stock Lunch: Cigna, Coinbase, & Draft Kings

Victoria Greene, G Squared Private Wealth CIO, joins CNBC's 'Power Lunch' to discuss three stocks: Cigna, Coinbase, and Draft Kings.

3-Stock Lunch: Cigna, Coinbase, & Draft Kings

The Motley Fool

Why Cigna Stock Popped Today

The healthcare company put merger rumors to bed.

Why Cigna Stock Popped Today

Why Cigna Deal With Humana Made Little Sense To Begin With

The Cigna Group confirmed “it is not pursuing a combination with Humana.”

Why Cigna Deal With Humana Made Little Sense To Begin With

Schaeffers Research

2 Healthcare Stocks in Focus After Merger Talks Break Down

Shares of Humana Inc (NYSE:HUM) are down 3.7% at $277.38 at last glance, after Cigna Group (NYSE:CI) said it was not pursuing a merger with the smaller health insurance name, and will instead prioritize share buybacks.

2 Healthcare Stocks in Focus After Merger Talks Break Down

Proactive Investors

Cigna rallies after Humana mega-merger called off

US health insurer Cigna has made the appropriate decision to ditch plans to merge with rival Humana (NYSE:HUM), if today's market reaction is anything to go by. Rumours of the merger, which would have created a $140 billion insurance behemoth, began circulating last December, but doubts over the deal quickly followed.

Cigna rallies after Humana mega-merger called off

Humana Stock Tumbles. Cigna Won't Pursue the Health Insurer.

Investors have long appeared skeptical about a potential merger between the two health insurers.

Humana Stock Tumbles. Cigna Won't Pursue the Health Insurer.

Cigna says it will not pursue combination with Humana

Health insurer Cigna Group said on Monday it is not pursuing a combination with peer Humana.

Cigna says it will not pursue combination with Humana

The Cigna Group Affirming Its Capital Priorities

Reaffirming Previously Provided Outlook for Full-Year 2024, and adjusted EPS growth of at least 10% in 2025 Confirming it is not Pursuing a Combination with Humana Inc. Confirming Continuing to Use Capital to Drive Shareholder Value, including Share Repurchase and Dividends BLOOMFIELD, Conn. , Nov. 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) officials expect to participate in meetings with investors and analysts over the next several weeks.

The Cigna Group Affirming Its Capital Priorities

See News Rankings

Charts implemented using Lightweight Charts™